Oncocine is a biotechnology company developing AI-powered personalised cancer vaccines for precision immunotherapy. Its ONVAC platform integrates patient-specific mutation profiles, tumour microenvironment insights, and immunogenicity prediction to design vaccine candidates tailored to each individual. By unifying key genomic and immunologic signals, Oncocine aims to enhance the precision of cancer treatment
Subscribe to our newsletter to stay up to date with the latest news.
